Clinical Trial of Ingenol Mebutate Gel 0.015% & 0.05% in Actinic Keratosis
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
This study evaluate the efficacy and safety of ingenol mebutate gel 0.015% on face and scalp
& 0.05% on trunk and extremities in Korean patient with actinic keratosis.
Phase:
Phase 4
Details
Lead Sponsor:
Korea University
Collaborators:
Ajou University School of Medicine Asan Medical Center Chonnam National University Hospital Dong-A University Hospital Korea University Anam Hospital LEO Pharma Samsung Medical Center Seoul National University Bundang Hospital Seoul National University Hospital Severance Hospital